AnaptysBio's Split Announcement Seems 'Awkward' Amid Clinical Activities, Truist Securities Says

Published 1 month ago • Sep 30, 2025 at 3:07 PM • Positive

AnaptysBio's (ANAB) recent announcement of its decision to explore a split into two companies seems

PREMIUM

Upgrade to read this MT Newswires article and get so much more.

A Silver or Gold subscription plan is required to access premium news articles.

Upgrade

Already have a subscription? Sign in

Menu

AnaptysBio's Split Announcement Seems 'Awkward' Amid Clinical Activities, Truist Securities Says

Related Stocks

More News

JAMF INVESTIGATION REMINDER: The Jamf Holding Corp. Board May have Breached its Fiduciary Duties – Shareholders Urged to Contact BFA Law

LRN INVESTIGATION REMINDER: Stride, Inc. Investors with Losses May have been Affected by Fraud – Contact BFA Law

MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors with Losses May have been Affected by Fraud – Contact BFA Law by December 15 Legal Deadline

Morning Crypto Report: XRP Spikes 250% in Profit-Taking, 73,880,192,530 SHIB Leave Binance Into Unknown, $1.12 Billion Bitcoin Sell-Off Threat Scares Crypto Market

Jim Cramer Says Haleon’s “Stock’s Been Struggling”